Abstract
Background
To compare pain score of single spot short duration time (20 milliseconds) panretinal photocoagulation (PRP) with conventional (100 milliseconds) PRP in diabetic retinopathy.
Methods
Sixty-six eyes from 33 patients with symmetrical severe non-proliferative diabetic retinopathy (non-PDR) or proliferative diabetic retinopathy (PDR) were enrolled in this prospective randomized controlled trial. One eye of each patient was randomized to undergo conventional and the other eye to undergo short time PRP. Spot size of 200 μm was used in both laser types, and energy was adjusted to achieve moderate burn on the retina. Patients were asked to mark the level of pain felt during the PRP session for each eye on the visual analog scale (VAS) and were examined at 1 week, and at 1, 2, 4 and 6 months.
Results
Sixteen women and 17 men with mean age 58.9 ± 7.8 years were evaluated. The conventional method required a mean power of 273 ± 107 mW, whereas the short duration method needed 721 ± 406 mW (P = 0.001). An average of 1,218 ± 441 spots were delivered with the conventional method and an average of 2,125 ± 503 spots were required with the short duration method (P = 0.001). Average pain score was 7.5 ± 1.14 in conventional group and 1.75 ± 0.87 in the short duration group (P = 0.001). At 1 week, 1 month, and 4 months following PRP, the mean changes of central macular thickness (CMT) from baseline in the conventional group remained 29.2 μm (P = 0.008), 40.0 μm (P = 0.001), and 40.2 μm (P = 0.007) greater than the changes in CMT for short time group.
Conclusion
Patient acceptance of short time single spot PRP was high, and well-tolerated in a single session by all patients. Moreover, this method is significantly less painful than but just as effective as conventional laser during 6 months of follow-up. The CMT change was more following conventional laser than short time laser.
Similar content being viewed by others
References
The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy (DRS) findings, DRS report number 8. Ophthalmology 88:583–600
Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU, Jorge R (2008) Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 86:385–389
Zakrzewski PA, O’Donnell HL, Lam WC (2009) Oral versus topical diclofenac for pain prevention during panretinal photocoagulation. Ophthalmology 116:1168–1744
Wu WC, Hsu KH, Chen TL, Hwang YS, Lin KK, Li ML, Shih CP, Lai CC (2006) Interventions for relieving pain associated with panretinal photocoagulation: a prospective randomized trial. Eye 20:712–719
Tesha PE, Giavedoni LR, Berger AR, Altomare F, Chow DR, Navajas EV, Yoganathan P, Wong DT, Principe A (2010) SubconjunctivalLidocaine before laser treatment, a randomized trial. Ophthalmology 117:1810–1814
Aideanu D, Taylor P, McAndrew P, Hildreth A, Deady JA, Stee DH (2006) Double masked randomised controlled trial to assess the effectiveness of paracetamol in reducing pain in panretinal photocoagulation. Br J Ophthalmol 90:713–717
Richardson C, Waterman H (2009) Pain relief during panretinal photocoagulation for diabetic retinopathy: a national survey. Eye 23:2233–2237
Ko BW, Shim JW, Lee BR, Cho HY (2009) Analgesic effects of tramadol during panretinal photocoagulation. Korean J Ophthalmol 23:273–276
Muqit MMK GR, Gray JCB, McLauchlan R, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE (2010) Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2. Br J Ophthalmol 94:1493–1498
Luttrull JK, Musch DC, Spink CA (2008) Subthreshold diode micropulsepanretinal photocoagulation for proliferative diabetic retinopathy. Eye 22:607–612
Blumenkranz MS, Yellachich D, Andersen DE, Wiltberger MW, Mordaunt D, Marcellino GR, Palanker D (2006) Semiautomated patterned scanning laser for retinal photocoagulation. Retina 26:370–376
Jain A, Blumenkranz MS, Paulus Y, Wiltberger MW, Andersen DE, Huie P, Palanker D (2008) Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol 126:78–85
Al-Hussainy S, Dodson PM, Gibson JM (2008) Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye 22:96–99
Nagpal M, Marlecha S, Nagpal K (2010) Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multi spot pattern scan laser. Retina 30:452–458
Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E (2010) Microperimetry and fundus autofluorescence in diabetic macular edema: subthresholdmicropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 30:908–916
Laursen ML, Moeller F, Sander B, Sjoelie AK (2004) Subthresholdmicropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 88:1173–1179
Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF, Cunha-Vaz JG, Chong NV (2009) Prospective randomized controlled trial comparing subthresholdmicropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 93:1341–1344
Muqit MM, Wakely L, Stanga PE, Henson DB, Ghanchi FD (2010) Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy. Eye 24:1136–1142
Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Charles SJ, Turner GS, Stanga PE (2009) Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 100 and 20 millisecond Pascal retinal photocoagulation treatment. Br J Ophthalmol 93:518–525
Desmettre TJ, Mordon SR, Buzawa DM, Mainster MA (2006) Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters. Br J Ophthalmol 90:709–712
Mainster MA (1999) Decreasing retinal photocoagulation damage: principles and techniques. Sem Ophthalmol 14:200–209
Roider J, Hillenkamp F, Flotte T, Birngruber R (1993) Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci USA 90:8643–8647
Paulus YM, Jain A, Gariano RF, Stanzel BV, Marmor M, Blumenkranz MS, Palanker D (2008) Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci 49:5540–5545
Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S, Tamai M (2003) Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 110:2386–2394
Lee SB, Yun YJ, Kim SH, Kim JY (2010) Changes in macular thickness after panretinal photocoagulation in patients with severe diabetic retinopathy and no macular edema. Retina 30:756–760
Henricsson M, Heiji A (1994) The effect of panretinal photocoagulation on visual acuity, visual field and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy. Acta Ophthalmol 72:570–575
Higgins KE, Meyers SM, Jaffe MJ, Roy MS, de Monasterio FM (1986) Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation. Arch Ophthalmol 104:997–1003
McDonald HR, Schatz H (1985) Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 92:388–393
McDonald HR, Schatz H (1985) Macular edema following panretinal photocoagulation. Retina 5:5–10
Diabetic retinopathy clinical research network, Brucker AJ, Qin H, Antoszyk AN, Beck RW, Bressler NM, Browning DJ, Elman MJ, Glassman AR, Gross JG, Kollman C, Wells JA (2009) Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol 127:132–140
Yi Q, Bamroongsuk P, McCarty DJ, Mukesh BN, Harper CA (2003) Clinical outcomes following laser photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital. Clin Exp Ophthalmol 31:305–309
Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine SL (2000) One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am J Ophthalmol 129:178–185
Acknowledgment
This study was supported by grants from Tehran University of Medical Science.
Financial Interests
The authors do not have any financial interests to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Authors have full control of all primary data, and they agree to allow Graefe's Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Clinical trial registration number: www.irct.ir IRCT138811073178N1
Rights and permissions
About this article
Cite this article
Mirshahi, A., Lashay, A., Roozbahani, M. et al. Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 251, 1103–1107 (2013). https://doi.org/10.1007/s00417-012-2167-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2167-5